Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
This study has been completed.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by:
First received: September 13, 2005
Last updated: May 16, 2011
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2007|
|Primary Completion Date:||No date given|